(1) The following notifiable conditions are public
health emergencies and suspect cases shall be reported immediately
by phone to the local health authority or the regional director of
the Department of State Health Services (department): anthrax; botulism;
carbapenem resistant Enterobacteriaceae (CRE);
diphtheria; measles (rubeola); meningococcal infection, invasive;
multi-drug resistant (MDR) Acinetobacter -MDR;
novel coronavirus causing severe acute respiratory disease; poliomyelitis,
acute paralytic; plague; novel influenza; rabies; smallpox; tularemia;
viral hemorrhagic fevers; yellow fever; and any outbreak, exotic disease,
or unusual group expression of disease that may be of public health
concern. Vancomycin-intermediate resistant Staphylococcus
aureus (VISA) and vancomycin-resistant Staphylococcus
aureus (VRSA) shall be reported immediately by phone to the
Emerging and Acute Infectious Disease Branch, Department of State
Health Services, Austin at (800) 252-8239.
(2) The following notifiable conditions shall be reported
within one working day of identification as a suspected case: brucellosis,
hepatitis A (acute), influenza-associated pediatric mortality, perinatal
hepatitis B, pertussis, Q fever, poliovirus infection, non-paralytic,
rubella (including congenital), tuberculosis, Vibrio
infection (including cholera).
(3) AIDS, chancroid, Chlamydia
trachomatis infection, gonorrhea, HIV infection, and syphilis
shall be reported in accordance with §§97.132 - 97.134 of
this title (relating to Sexually Transmitted Diseases Including Acquired
Immune Deficiency Syndrome (AIDS) and Human Immunodeficiency Virus
(4) Tuberculosis antibiotic susceptibility results
should be reported by laboratories no later than one week after they
first become available.
(5) For all other notifiable conditions not listed
in paragraphs (1) - (3) of this subsection, reports of disease shall
be made no later than one week after a case or suspected case is identified.
(6) All anthrax (Bacillus
anthracis), botulism-adult and infant (Clostridium
botulinum), brucellosis (Brucella species), E.coli 0157:H7 or other Shiga-toxin producing E. coli, isolates or specimens from cases
where Shiga-toxin activity is demonstrated, Listeria
monocytogenes, meningococcal infection, invasive (Neisseria meningitides) from normally sterile
sites or purpuric lesions, plague (Yersinia
pestis), tuberculosis (Mycobacterium
tuberculosis complex), tularemia (Francisella
tularensis), VISA, VRSA and Vibrio species
shall be submitted as pure cultures to the Department of State Health
Services, Laboratory Services Section, 1100 West 49th Street, Austin,
Texas 78756-3199 as they become available.
(b) Animals. Reportable conditions affecting animals
shall be reported within one working day following the diagnosis.
|Source Note: The provisions of this §97.4 adopted to be effective March 16, 1994, 19 TexReg 1453; amended to be effective July 26, 1996, 21 TexReg 6622; amended to be effective March 5, 1998, 23 TexReg 1954; amended to be effective January 1, 1999, 23 TexReg 12663; amended to be effective December 20, 2000, 25 TexReg 12426; amended to be effective August 5, 2001, 26 TexReg 5658; amended to be effective December 12, 2002, 27 TexReg 11547; amended to be effective June 5, 2007, 32 TexReg 2997; amended to be effective December 20, 2012, 37 TexReg 9777; amended to be effective April 20, 2014, 39 TexReg 2853